Travel grant 2024, Korea, BIOKOREA, 8-10 May 2024

Important results from the project

Having successfully established collaborations with top Japanese pharma companies, Salipro now seeks to engage with new stakeholders across sectors to showcase our technology for the discovery of novel medicines against inaccessible drug targets. Our objective is to forge new relations with leading biotech and pharma companies in Asia and identify potential partners within the Korean pharma industry for advancing drug discovery programs. At Bio Korea we aim to foster our existing partnerships in Asia and also gain insights into market opportunities in the region’s pharma sector.

Expected long term effects

Under this project, we expect to gain deeper insights into the Korean pharma and biotech market and explore potential business opportunities within this sector. We anticipate establishing new connections and engaging with key stakeholders from the biotech and pharma industry in Korea. Our presence at the event will give us the opportunity to demonstrate our technology with the aim of establishing future partnerships with Korean pharma companies. Ultimately, with this participation, Salipro Biotech aims to further contribute to the growth of Sweden’s biotech industry landscape.

Approach and implementation

By attending Bio Korea 2024 together with the Swedish Biopharma Delegation, Salipro Biotech is set to participate in various activities on-site, including exhibitions, networking sessions, one-on- one partnering meetings, and company presentations. Upon participation in Bio Korea, we aim to continue our discussions and explore potential ways to collaborate by actively requesting meetings with potential Korean partners.